Cited 58 times in
Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 안상훈 | - |
dc.date.accessioned | 2014-12-19T17:45:31Z | - |
dc.date.available | 2014-12-19T17:45:31Z | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 0264-410X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/92001 | - |
dc.description.abstract | Adults 40 years of age and older have been shown to be hypo-responsive immunologically to the currently available hepatitis B virus (HBV) vaccines. Three intramuscular doses of a Toll-like receptor 9 agonist, 1018 immunostimulatory sequence (1018 ISS) adjuvant, combined with recombinant hepatitis B surface antigen (HBsAg) demonstrated faster, superior, and more durable seroprotection than three doses of a licensed comparator HBV vaccine (Engerix-B(®)). This investigational vaccine, HBsAg-1018 ISS, was well tolerated with a safety profile similar to the comparator vaccine. These results suggest that HBsAg-1018 may be more effective in this hypo-responsive population | - |
dc.description.statementOfResponsibility | open | - |
dc.language | VACCINE | - |
dc.publisher | VACCINE | - |
dc.relation.isPartOf | VACCINE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adjuvants, Immunologic | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Antibodies, Viral/blood | - |
dc.subject.MESH | Antibodies, Viral/immunology | - |
dc.subject.MESH | Double-Blind Method | - |
dc.subject.MESH | Drug-Related Side Effects and Adverse Reactions | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Hepatitis B/immunology | - |
dc.subject.MESH | Hepatitis B/prevention & control* | - |
dc.subject.MESH | Hepatitis B/virology | - |
dc.subject.MESH | Hepatitis B Surface Antigens/genetics | - |
dc.subject.MESH | Hepatitis B Surface Antigens/immunology | - |
dc.subject.MESH | Hepatitis B Vaccines/adverse effects | - |
dc.subject.MESH | Hepatitis B Vaccines/genetics | - |
dc.subject.MESH | Hepatitis B Vaccines/immunology* | - |
dc.subject.MESH | Hepatitis B virus/immunology* | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Immunity, Humoral | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Oligodeoxyribonucleotides/genetics | - |
dc.subject.MESH | Oligodeoxyribonucleotides/immunology | - |
dc.subject.MESH | Placebos | - |
dc.subject.MESH | Toll-Like Receptor 9/agonists | - |
dc.subject.MESH | Toll-Like Receptor 9/genetics | - |
dc.subject.MESH | Toll-Like Receptor 9/immunology | - |
dc.title | Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Benjamin P. Sablan | - |
dc.contributor.googleauthor | Dong Joon Kim | - |
dc.contributor.googleauthor | Nina G. Barzaga | - |
dc.contributor.googleauthor | Wan Cheng Chow | - |
dc.contributor.googleauthor | Mong Cho | - |
dc.contributor.googleauthor | Sang Hoon Ahn | - |
dc.contributor.googleauthor | Seong Gyu Hwang | - |
dc.contributor.googleauthor | JiHyun Lee | - |
dc.contributor.googleauthor | Hamid Namini | - |
dc.contributor.googleauthor | William L. Heyward | - |
dc.identifier.doi | 10.1016/j.vaccine.2012.02.001 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02226 | - |
dc.relation.journalcode | J02776 | - |
dc.identifier.eissn | 1358-8745 | - |
dc.identifier.pmid | 22342916 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S0264410X1200165X | - |
dc.subject.keyword | Hepatitis B vaccine | - |
dc.subject.keyword | Seroprotection | - |
dc.subject.keyword | Older adults | - |
dc.contributor.alternativeName | Ahn, Sang Hoon | - |
dc.contributor.affiliatedAuthor | Ahn, Sang Hoon | - |
dc.citation.volume | 30 | - |
dc.citation.number | 16 | - |
dc.citation.startPage | 2689 | - |
dc.citation.endPage | 2696 | - |
dc.identifier.bibliographicCitation | VACCINE, Vol.30(16) : 2689-2696, 2012 | - |
dc.identifier.rimsid | 30062 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.